Literature DB >> 34496200

Effect of Vaccination on Transmission of SARS-CoV-2.

Anoop S V Shah1, Ciara Gribben2, Jennifer Bishop2, Peter Hanlon3, David Caldwell2, Rachael Wood4, Martin Reid2, Jim McMenamin2, David Goldberg2, Diane Stockton2, Sharon Hutchinson5, Chris Robertson6, Paul M McKeigue4, Helen M Colhoun4, David A McAllister7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34496200      PMCID: PMC8451182          DOI: 10.1056/NEJMc2106757

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
To the Editor: Whether vaccination of individual persons for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protects members of their households is unclear. We investigated the effect of vaccination of health care workers in Scotland (who were among the earliest groups to be vaccinated worldwide) on the risk of coronavirus disease 2019 (Covid-19) among members of their households. We evaluated data from 194,362 household members (which represented 92,470 households of 2 to 14 persons per household) of 144,525 health care workers who had been employed during the period from March 2020 through November 2020. The mean ages of the household members and the health care workers were 31 and 44 years, respectively; a majority (>96%) were White. A total of 113,253 health care workers (78.4%) had received at least one dose of either the BNT162b2 (Pfizer–BioNTech) mRNA vaccine or the ChAdOx1 nCoV-19 (Oxford–AstraZeneca) vaccine, and 36,227 (25.1%) had received a second dose. The primary outcome was any confirmed case of Covid-19 that occurred between December 8, 2020, and March 3, 2021. We also report results for Covid-19–associated hospitalization. The primary time periods we compared were the unvaccinated period before the first dose and the period beginning 14 days after the health care worker received the first dose. No adjustment was made for multiplicity. Events that occurred after any household member was vaccinated were censored. Detailed methods and results, strengths and limitations, and the protocol are provided in the Supplementary Appendix, which is available with the full text of this letter at NEJM.org. This study was approved by the Public Benefit and Privacy Panel (2021-0013), and the scientific officer of the West of Scotland Research Ethics Committee provided written confirmation that formal ethics review was not required. Cases of Covid-19 were less common among household members of vaccinated health care workers during the period beginning 14 days after the first dose than during the unvaccinated period before the first dose (event rate per 100 person-years, 9.40 before the first dose and 5.93 beginning 14 days after the first dose). After the health care worker’s second dose, the rate in household members was lower still (2.98 cases per 100 person-years). These differences persisted after fitting extended Cox models that were adjusted for calendar time, geographic region, age, sex, occupational and socioeconomic factors, and underlying conditions. Relative to the period before each health care worker was vaccinated, the hazard ratio for a household member to become infected was 0.70 (95% confidence interval [CI], 0.63 to 0.78) for the period beginning 14 days after the first dose and 0.46 (95% CI, 0.30 to 0.70) for the period beginning 14 days after the second dose (Table 1 and the Supplementary Appendix). Not all the cases of Covid-19 in the household members were transmitted from the health care worker; therefore, the effect of vaccination may be larger.[1] For example, if half the cases in the household members were transmitted from the health care worker, a 60% decrease in cases transmitted from health care workers would need to occur to elicit the association we observed (see the Supplementary Appendix). Vaccination was associated with a reduction in both the number of cases and the number of Covid-19–related hospitalizations in health care workers between the unvaccinated period and the period beginning 14 days after the first dose.
Table 1

Effect of Vaccination of Health Care Workers on Documented Covid-19 Cases and Hospitalizations in Health Care Workers and Their Households.*

VariableHealth Care WorkersHousehold Members
Unvaccinated PeriodPeriod Beginning14 Days afterFirst DoseHazard Ratio(95% CI)Unvaccinated PeriodPeriod Beginning14 Days afterFirst DoseHazard Ratio(95% CI)
Cases
No. of patients144,525109,074194,362148,366
No. of events3191115220371086
Mean person-time — days40454145
Rate per 100 person-yr20.138.519.405.93
Comparison of rates per 100 person-yr
Unadjusted model0.51 (0.48–0.55)0.74 (0.67–0.82)
Model 10.52 (0.49–0.56)0.73 (0.66–0.81)
Model 20.55 (0.51–0.59)0.75 (0.68–0.83)
Model 30.45 (0.42–0.49)0.71 (0.63–0.78)
Model 40.45 (0.42–0.49)0.70 (0.63–0.78)
Hospitalizations
No. of patients144,525111,081194,362149,689
No. of events1581911164
Mean person-time — days41454145
Rate per 100 person-yr0.970.140.510.35
Comparison of rates per 100 person-yr
Unadjusted model0.16 (0.10–0.27)0.83 (0.58–1.17)
Model 10.16 (0.10–0.27)0.81 (0.57–1.15)
Model 20.17 (0.10–0.29)0.86 (0.61–1.23)
Model 30.15 (0.09–0.26)0.77 (0.53–1.10)
Model 40.16 (0.09–0.27)0.77 (0.53–1.10)

Results are shown for Cox regression models stratified according to health board geographic region, with calendar time as the timescale and the vaccination status as a time-varying covariate. The models were adjusted sequentially for age (with the use of a penalized spline to allow for nonlinearity) and sex (model 1); for category on the Scottish Index of Multiple Deprivation (a measure of socioeconomic deprivation based on geographic region) and ethnic group (model 2); for health care worker role (patient-facing, non–patient-facing, or undetermined), occupation, and part-time status (model 3); and for coexisting conditions (as both a count of coexisting conditions and the presence or absence of type 2 diabetes) (model 4). Covid-19 denotes coronavirus disease 2019.

Cases were defined on the basis of results of a polymerase-chain-reaction test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA (estimated at 90% sensitivity and 99% specificity in Scotland-Wellcome Open Res 2020;5:254. DOI:10.12688/wellcomeopenres.16342.1).

In sensitivity analyses that tested the robustness of the findings of the primary analysis to the proportional-hazards assumption, all the covariates were instead included as stratifying variables in the extended Cox models. Age was categorized in 10-year bands (e.g., 20 to 29 years of age), with the remaining covariates treated as unordered categorical variables. In these models, the hazard ratio for a health care worker to become infected was 0.44 (95% CI, 0.40 to 0.47), and the hazard ratio for a household member to become infected was 0.68 (95% CI, 0.62 to 0.75).

Given that vaccination reduces asymptomatic infection with SARS-CoV-2,[2,3] it is plausible that vaccination reduces transmission; however, data from clinical trials and observational studies are lacking.[4,5] We provide empirical evidence suggesting that vaccination may reduce transmission by showing that vaccination of health care workers is associated with a decrease in documented cases of Covid-19 among members of their households. This finding is reassuring for health care workers and their families.
  56 in total

Review 1.  Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries.

Authors:  Fabrizio Bert; Giacomo Scaioli; Lorenzo Vola; Davide Accortanzo; Giuseppina Lo Moro; Roberta Siliquini
Journal:  Int J Environ Res Public Health       Date:  2022-06-13       Impact factor: 4.614

2.  Acute cardiac side effects after COVID-19 mRNA vaccination: a case series.

Authors:  Noemi F Freise; Milena Kivel; Olaf Grebe; Christian Meyer; Bahram Wafaisade; Matthias Peiper; Tobias Zeus; Jan Schmidt; Judith Neuwahl; Danny Jazmati; Tom Luedde; Edwin Bölke; Torsten Feldt; Björn Erik Ole Jensen; Johannes Bode; Verena Keitel; Jan Haussmann; Balint Tamaskovics; Wilfried Budach; Johannes C Fischer; Wolfram Trudo Knoefel; Marion Schneider; Peter Arne Gerber; Alessia Pedoto; Dieter Häussinger; Martijn van Griensven; Amir Rezazadeh; Yechan Flaig; Julian Kirchner; Gerald Antoch; Hubert Schelzig; Christiane Matuschek
Journal:  Eur J Med Res       Date:  2022-06-02       Impact factor: 4.981

3.  Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.

Authors:  Vicente Jover Cerdá; Ramón Rodríguez Pacheco; Joan Doménech Witek; Sonia Alonso Hernández; Rafael Durán García; Marina Real Panisello; Francisco Manuel Marco de la Calle
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-27       Impact factor: 3.373

4.  Transmission of SARS-CoV-2 within households: a remote prospective cohort study in European countries.

Authors:  Janneke D M Verberk; Marieke L A de Hoog; Ilse Westerhof; Sam van Goethem; Christine Lammens; Greet Ieven; Erwin de Bruin; Dirk Eggink; Julia A Bielicki; Samuel Coenen; Janko van Beek; Marc J M Bonten; Herman Goossens; Patricia C J L Bruijning-Verhagen
Journal:  Eur J Epidemiol       Date:  2022-05-28       Impact factor: 12.434

Review 5.  Asymptomatic and pre-symptomatic infection in Coronavirus Disease 2019 pandemic.

Authors:  Yutong Wang; Ke Zheng; Wenjing Gao; Jun Lv; Canqing Yu; Lan Wang; Zijun Wang; Bo Wang; Chunxiao Liao; Liming Li
Journal:  Med Rev (Berl)       Date:  2022-02-24

6.  The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity.

Authors:  Jonathan Pugh; Julian Savulescu; Rebecca C H Brown; Dominic Wilkinson
Journal:  J Med Ethics       Date:  2022-03-07       Impact factor: 5.926

7.  Household transmission of SARS-CoV-2 from unvaccinated asymptomatic and symptomatic household members with confirmed SARS-CoV-2 infection: an antibody-surveillance study.

Authors:  Maala Bhatt; Amy C Plint; Ken Tang; Richard Malley; Anne Pham Huy; Candice McGahern; Jennifer Dawson; Martin Pelchat; Lauren Dawson; Terry Varshney; Corey Arnold; Yannick Galipeau; Michael Austin; Nisha Thampi; Fuad Alnaji; Marc-André Langlois; Roger L Zemek
Journal:  CMAJ Open       Date:  2022-04-12

8.  Caveats on COVID-19 herd immunity threshold: the Spain case.

Authors:  David García-García; Enrique Morales; Eva S Fonfría; Isabel Vigo; Cesar Bordehore
Journal:  Sci Rep       Date:  2022-01-12       Impact factor: 4.379

9.  Spatiotemporal Associations between Local Safety Level Index and COVID-19 Infection Risks across Capital Regions in South Korea.

Authors:  Youngbin Lym; Hyobin Lym; Keekwang Kim; Ki-Jung Kim
Journal:  Int J Environ Res Public Health       Date:  2022-01-12       Impact factor: 3.390

Review 10.  Animal models of SARS-CoV-2 transmission.

Authors:  Rory D de Vries; Barry Rockx; Bart L Haagmans; Sander Herfst; Marion Pg Koopmans; Rik L de Swart
Journal:  Curr Opin Virol       Date:  2021-06-29       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.